Cargando…

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials

Despite centuries since the discovery and study of cancer, cancer is still a lethal and intractable health issue worldwide. Cancer-associated fibroblasts (CAFs) have gained much attention as a pivotal component of the tumor microenvironment. The versatility and sophisticated mechanisms of CAFs in fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hao, Yue, Xinghai, Chen, Zhe, Liu, Chao, Wu, Wantao, Zhang, Nan, Liu, Zaoqu, Yang, Liping, Jiang, Qing, Cheng, Quan, Luo, Peng, Liu, Guodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544417/ https://www.ncbi.nlm.nih.gov/pubmed/37784082 http://dx.doi.org/10.1186/s12943-023-01860-5

Ejemplares similares

Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers
por: Pei, Liping, et al.
Publicado: (2023)

Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer
por: Geng, Xinglong, et al.
Publicado: (2021)

Dysregulation of miRNA Expression in Cancer Associated Fibroblasts (CAFs) and Its Consequences on the Tumor Microenvironment
por: Schoepp, Maren, et al.
Publicado: (2017)

Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
por: Wang, Yuchen, et al.
Publicado: (2022)

The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer
por: Stouten, Imke, et al.
Publicado: (2023)

A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy
por: Li, He, et al.
Publicado: (2022)

Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer
por: Wang, Ganggang, et al.
Publicado: (2023)

Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis
por: Liu, Yuanyuan, et al.
Publicado: (2022)

CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?
por: Zhang, Chunxue, et al.
Publicado: (2023)

Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets
por: Guo, Aiyuan, et al.
Publicado: (2022)

Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer
por: Mishra, Deepshikha, et al.
Publicado: (2023)

Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET
por: Gilardi, Laura, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Immunological Role of PDIA5: A Potential Target for Immunotherapy
por: Chen, Yu, et al.
Publicado: (2022)

Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment
por: Zhang, Yue, et al.
Publicado: (2023)

Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment
por: Nguyen, Elizabeth V., et al.
Publicado: (2019)

Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy
por: Zhang, Hongyan, et al.
Publicado: (2023)

Senescent Fibroblasts Generate a CAF Phenotype through the Stat3 Pathway
por: Li, Hao, et al.
Publicado: (2022)

Pancreatic Cancer Associated Fibroblasts (CAF): Under-Explored Target for Pancreatic Cancer Treatment
por: Norton, Jeffrey, et al.
Publicado: (2020)

Tumor microenvironment and immunotherapy of oral cancer
por: Liu, Chang, et al.
Publicado: (2022)

Dangerous Liaisons: Circulating Tumor Cells (CTCs) and Cancer-Associated Fibroblasts (CAFs)
por: Hurtado, Pablo, et al.
Publicado: (2020)

Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma
por: Zhang, Nan, et al.
Publicado: (2022)

Overexpression of α-sma-positive fibroblasts (CAFs) in Nasopharyngeal Carcinoma Predicts Poor Prognosis
por: Chen, Jiewei, et al.
Publicado: (2017)

Identification of the novel therapeutic targets and biomarkers associated of prostate cancer with cancer-associated fibroblasts (CAFs)
por: Zhai, Xinyu, et al.
Publicado: (2023)

Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer
por: Wang, Linlin, et al.
Publicado: (2017)

Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response
por: Chen, Rui, et al.
Publicado: (2022)

Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment
por: Zhang, Nan, et al.
Publicado: (2021)

Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin
por: Omland, Silje Haukali, et al.
Publicado: (2017)

Different Expression and Clinical Implications of Cancer-Associated Fibroblast (CAF) Markers in Brain Metastases
por: Akanda, Md Rashedunnabi, et al.
Publicado: (2023)

CAF-immune cell crosstalk and its impact in immunotherapy
por: Maia, Ana, et al.
Publicado: (2022)

Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data
por: Yu, Lianghe, et al.
Publicado: (2022)

Corrigendum: Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response
por: Chen, Rui, et al.
Publicado: (2022)

Brcal Defective Breast Cancer Cells Induce in vitro Transformation of Cancer Associated Fibroblasts (CAFs) to Metastasis Associated Fibroblasts (MAF)
por: Hemalatha, Sreelatha K., et al.
Publicado: (2018)

Fight the Cancer, Hit the CAF!
por: Papait, Andrea, et al.
Publicado: (2022)

Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs)
por: Vivacqua, Adele, et al.
Publicado: (2015)

A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancer
por: Burley, Amy, et al.
Publicado: (2022)

Expression Patterns of Glycosylation Regulators Define Tumor Microenvironment and Immunotherapy in Gastric Cancer
por: Li, Fang, et al.
Publicado: (2022)

Large-scale bulk RNA-seq analysis defines immune evasion mechanism related to mast cell in gliomas
por: Chen, Rui, et al.
Publicado: (2022)

Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
por: Noman, Muhammad Zaeem, et al.
Publicado: (2019)

Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
por: Haubeiss, Silke, et al.
Publicado: (2010)

Correction to: Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin
por: Omland, Silje Haukali, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c75m78tp8fbs81mpg1cm26r6fl